Insiders · Profile

Zulueta Alfonso G

SVP & President, Lilly Int'l at Lilly (Eli) · Director at CTS. Filing since 29 Jan 2016. CIK 0001596336

Company
Date
Role
Action
Shares
Amount
Of holding
9 Jul 2020
SVP & President, Lilly Int'l
Sold, plan not stated
11,000
$1.87M
37.1%
16 Jun 2020
SVP & President, Lilly Int'l
Sold, plan not stated
17,000
$2.77M
36.4%
5 Jun 2020
SVP & President, Lilly Int'l
Sold, plan not stated
10,000
$1.50M
17.7%
13 Mar 2020
Director
Bought
940
$20.84K
7.8%
12 Mar 2020
Director
Bought
863
$18.63K
7.7%
11 Mar 2020
Director
Bought
860
$20.17K
8.3%
10 Mar 2020
Director
Bought
850
$19.98K
8.9%
9 Mar 2020
Director
Bought
900
$19.97K
10.5%
6 Dec 2019
SVP & President, Lilly Int'l
Sold, plan not stated
4,500
$540.00K
13.3%
20 Sep 2019
SVP & President, Lilly Int'l
Sold, plan not stated
4,500
$526.50K
11.7%
3 Sep 2019
SVP & President, Lilly Int'l
Sold, plan not stated
19,500
$2.20M
33.7%
12 Apr 2019
SVP & President, Lilly Int'l
Sold, plan not stated
10,000
$1.25M
14.7%
31 Jan 2019
SVP & President, Lilly Int'l
Sold, plan not stated
4,000
$480.00K
8.8%
4 Oct 2018
SVP & President, Lilly Int'l
Sold, plan not stated
7,000
$802.48K
13.4%
18 Sep 2018
SVP & President, Lilly Int'l
Sold, plan not stated
3,000
$321.00K
5.4%
17 Sep 2018
SVP & President, Lilly Int'l
Sold, plan not stated
3,000
$316.83K
5.2%
4 Dec 2017
SVP & President, Lilly Int'l
Sold, plan not stated
3,532
$303.75K
8.1%
10 Nov 2017
SVP & President, Lilly Int'l
Sold, plan not stated
2,003
$167.59K
4.4%
6 Feb 2017
SVP& Pres., Emerging Markets
Sold, plan not stated
15,000
$1.16M
24.8%
27 Apr 2016
SVP& Pres., Emerging Markets
Sold, plan not stated
12,000
$915.24K
21.0%
29 Jan 2016
SVP& Pres., Emerging Markets
Sold, plan not stated
5,000
$393.75K
8.1%
21 decisions on file.